with negative free cash flow in the last twelve months. The Outperform rating by Raymond James suggests that the firm expects Gold Royalty’s stock performance to exceed the average return of the ...

Gold Royalty Corp (GROY), a $223.5 million market cap royalty company, reported its fourth-quarter 2024 financial results, revealing a wider-than-expected loss and lower revenue than forecasted, ...

This development adds to the company’s portfolio of generic pharmaceuticals ... In other recent news, ANI Pharmaceuticals has settled a royalty obligation with SWK Funding LLC for $17.25 ...

And the best part? Eligible customers can sign up for a 30-day free trial and experience the incredible benefits Prime offers without paying a penny upfront. Prime aims to make your life more ...

India’s top generics players like Dr Reddy’s, Sun Pharma, Biocon, Cipla and more are rushing to develop versions of GLP-1 drugs, including generic copies of Semaglutide. The drug will lose ...

As spotted by Android Authority readers and confirmed by Mishaal Rahman, the Live Updates feature has been partially switched on in Android 16 beta 2.1 — with Google Maps now able to utilize the ...

Generic drugs made in India cause 54% more severe adverse reactions than identical drugs made in the U.S., a study finds. The issue seems to stem from regulatory oversight differences, as FDA ...